Effect of Opicapone on sleep-related complaints and non-motor burden in Parkinson’s patients: A Post-Hoc analysis of the OASIS Trial

Ongentys (opicapone) - Ono Pharmaceutical, Neurocrine Biosciences, BIAL

https://journals.sagepub.com/doi/epub/10.1177/1877718X261451755

Daniela Marinho 1; Joaquim J. Ferreira 2; Miguel F. Gago 3; Raquel Costa 4; Miguel M. Fonseca 5; Helena C. Brigas 4; Joerg Holenz 6; Claudia Trenkwalder 7

Jun 2, 2026